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Double-stranded RNA is a potent inducer of interferon, a modulator of the expression of a number of other genes involved
in the response of cells to virus infection, an activator of the interferon-induced antiviral state, and may be involved in
differentiation, induction of apoptosis, and control of oncogenic transformation. This review will attempt to summarize what
is known about the cellular proteins that act to mediate the response of cells to double-stranded RNA and the viral and
cellular macromolecules that may be able to modulate these responses. q 1996 Academic Press, Inc.
THE PLAYERS these molecules in infected and perhaps uninfected
cells. Actually identifying the potential sources of dsRNA
Most viruses induce the synthesis of dsRNA2 at some in infected cells has in fact been problematic over the
time during their replication cycle. The presence of viral years. Minute quantities of dsRNA, as little as one mole-
dsRNA appears to trigger many of the cellular responses cule per cell (Marcus and Sekellick, 1977), can have pro-
to virus-infection, probably through activation of dsRNA- found effects on cellular physiology. It is difficult to detect
dependent enzymes, including the interferon-inducible such miniscule quantities of preexisting dsRNA in cell
protein kinase, PKR, and the interferon-inducible enzyme, extracts. This problem is exacerbated by the potential
2*,5* oligoadenylate synthetase. As countermeasures, reassociation of complementary strands of RNA during
many viruses have evolved mechanisms to mask the extract preparation, especially during extraction with
effects of dsRNA on cells. This review will first summarize phenol (Kohne et al., 1977), always calling into question
what is known about synthesis of dsRNA in virus-infected whether any isolated dsRNA preexisted in the cell or
(and perhaps uninfected) cells, will then tackle the was in fact an artifact of reassociation during isolation.
dsRNA-activatable enzymes that are present in cells, and Nonetheless, binding of anti-dsRNA antibodies to viro-
finally will review the viral and cellular products that can plasm of extracted whole cells (Lee et al., 1994a) and
modulate the cellular response to dsRNA. isolation of viral mutants that alter activation of dsRNA-
dependent processes (Kitajewski et al., 1986; Beattie et
SOURCES OF dsRNA al., 1991, 1995a,b; Chang et al., 1995) all suggest that
dsRNA does in fact exist within virus-infected cells.Before discussing the macromolecules in cells that
For viruses with dsRNA genomes the obvious suspectmediate the response to dsRNA it is important to get a
is the genome itself. However, completely uncoatedglimpse of the sources of RNA that can interact with
dsRNA genome has not been detected in cells infected
with dsRNA-viruses (Schiff and Fields, 1990). For the reo-
viruses, input viral dsRNA remains within the inner cap-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (602)965-0098. E-mail (Internet): idblj@asuvm.inre. sid throughout the viral life cycle, and progeny genome is
asu.edu. only synthesized after assembly of positive sense single-2 Abbreviations used: DRAD, dsRNA adenosine deaminase; dsRNA,
stranded progeny RNA into subviral particles. It is likelydouble-stranded RNA; E3L, the vaccinia virus gene coding for a dsRNA-
that the machinations that dsRNA viruses go through tobinding protein inhibitor of PKR; EBER, Epstein–Barr virus-encoded
small RNA; eIF-2, eukaryotic protein synthesis initiation factor 2; K3L, prevent exposure of naked dsRNA in cells is a conse-
the vaccinia virus gene coding for an eIF-2a homologue inhibitor of quence of the profound effects that dsRNA has on the
PKR; PKR, the interferon-inducible, dsRNA-dependent protein kinase; physiology of the cell. Nonetheless, it could be that mi-
RRE, the HIV rev responsive element; tar, the HIV tat responsive ele-
nute amounts of incorrectly uncoated or packaged ge-ment; tat, the HIV transactivator of gene expression; VAI RNA, adenovi-
nome might be present in infected cells and could acti-rus-encoded small RNA I; VAII RNA, adenovirus-encoded small RNA
II. vate the known dsRNA-dependent enzymes. Alterna-
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tively, secondary structure on mRNA might be involved in ently uninfected cells (Maran and Mathews, 1988; Li and
Petryshyn, 1991), which are capable of activating theactivating these enzymes in infected cells. Such structure
has been implicated in the poor translation of the reovi- dsRNA-dependent protein kinase, PKR, in vitro. This RNA
is apparently poly(A) rich and may contain topologicallyrus s1 mRNA (Henry et al., 1994).
For ssRNA viruses the obvious culprit is replicative unlinked complementary strands. Again, it is unclear if
these hybrids exist in cells or hybridize during RNA isola-intermediate in infected cells. This is supported by the
isolation of both positive and negative sense RNA bound tion, although PKR activation has been detected in differ-
entiating adipocytes (Li and Petryshyn, 1991), from whichto the dsRNA-binding protein 2*,5* oligoadenylate synthe-
tase from EMCV-infected cells (Gribaudo et al., 1991) dsRNA can be isolated, and after IL-3 deprivation of an
IL-3-dependent murine cell line (Ito et al., 1994).and by binding of antisera that recognizes dsRNA to
viroplasm in rubella and semliki forest virus-infected
cells (Lee et al., 1994a). Viral dsRNA isolated from influ- MEDIATORS OF THE CELLULAR RESPONSE
enza virus-infected lungs was able to induce both the TO dsRNA
local and systemic cytotoxic effects typical of influenza
virus-infection when injected into experimental animals Two of the cellular gene products whose activities are
most clearly regulated by dsRNA are the protein kinase,(Majde et al., 1991; Kimura et al., 1992). Again, however,
it is unclear how much true dsRNA, i.e., full duplexes PKR, and the enzyme 2*,5* oligoadenylate synthetase
(Sen and Lengyel, 1992; Pestka et al., 1987). Both en-between positive and negative sense RNA, exists in cells
infected with ssRNA viruses. zymes can be induced in cells treated with interferon,
and both enzymes can bind to and be potently activatedFor DNA viruses dsRNA appears to accumulate as
the result of overlapping convergent transcription. At late at a posttranslational step by dsRNA. In the case of PKR,
activation occurs concomitantly with intermoleculartimes after infection with vaccinia virus, viral transcripts
fail to terminate at discrete sites at the ends of genes (Kostura and Mathews 1989; Thomis and Samuel 1995)
and perhaps intramolecular (Berry et al., 1985; Galabru(Moss, 1990). Thus, complementary mRNAs are pro-
duced from genes transcribed in opposing directions et al., 1989) phosphorylation, which may be accompanied
by dimerization (Langland and Jacobs, 1992; Patel et al.,(Colby and Duesberg, 1969; Duesberg and Colby, 1969;
Colby et al., 1971; Boone et al., 1979). The vaccinia virus 1995). The level of PKR activation may be regulated in
cells by depletion of Ca/2 stores in the endoplasmicA18R gene product modulates transcription termination,
thereby altering the level of dsRNA that accumulates in reticulum (Prostko et al., 1995). Once activated, PKR can
phosphorylate a number of exogenous substrates includ-infected cells, with defects in A18R leading to excess
dsRNA (Bayliss and Condit, 1993; Simpson and Condit, ing the small (a) subunit of the protein synthesis initiation
factor eIF-2 (Farrell et al., 1977; Levin and London, 1978;1994). Similar complementary transcripts have been de-
tected in adenovirus- (Pettersson and Philipson, 1974; Samuel, 1979), the NFkB inhibitor IkB (Maran et al., 1994;
Kumar et al., 1994; Offermann et al., 1995), and histoneMaran and Mathews, 1988), herpes simplex virus- (Ja-
quemont and Roizman, 1975), and SV-40- (Aloni, 1972) proteins (Jacobs and Imani, 1988; Galabru and Hovanes-
sian, 1985). eIF-2a phosphorylation can lead to an inhibi-infected cells. Again, the actual extent of hybridization
between these complementary strands in infected cells tion of the initiation of protein synthesis. eIF-2a phos-
phorylation by PKR is presumed to be involved in theis unclear, although a large fraction of the RNA in vac-
cinia virus-infected cells is ribonuclease resistant even interferon-mediated inhibition of replication of a number
of viruses. Constitutive expression of either humanbefore deproteination (Colby et al., 1971). In addition,
activation of the dsRNA-dependent pathways has been (Meurs et al., 1992) or mouse (Baier et al. 1993) PKR
leads to an inhibition of replication of EMCV, but not VSV.detected in cells infected with either adenovirus (Kitajew-
ski et al., 1986) or vaccinia virus (Beattie et al., 1991, For both adenovirus (Kitajewski et al. 1986) and vaccinia
virus (Beattie et al., 1991, 1995a,b; Chang et al., 1995),1995a,b; Chang et al., 1995) deleted for inhibitors of these
pathways. deletion of inhibitors of PKR (VAI RNA for adenovirus and
the E3L or K3L genes for vaccinia virus) leads to in-While fully duplexed RNA has not been detected in
retrovirus-infected cells, the HIV and HTLV genomes con- creased phosphorylation of eIF-2a and renders these
normally interferon-resistant viruses sensitive to the ef-tain large domains of secondary structure (tar and RRE/
RxRE) that function to regulate gene expression and can fects of interferon. In the case of adenovirus, deletion of
the VAI gene can be complemented by overexpressioninteract with several dsRNA-binding proteins (Sengupta
and Silverman, 1989; Edery et al., 1989; Schroder et al., of a nonphosphorylatable variant of eIF-2a (Davies et al.,
1989). Phosphorylation of IkB by PKR can lead to IkB1990; Silverman and Sengupta, 1990; Gunnery et al.,
1990, 1992; Gatignol et al., 1993; Park et al., 1994; Maitra degradation and subsequent activation of NFkB (Maran
et al., 1994; Kumar et al., 1994; Offermann et al., 1995),et al., 1994).
Perhaps some of the most intriguing findings have perhaps through a reactive oxygen-mediated pathway
(Schreck et al., 1991). The activation of NFkB mediatedbeen the detection of dsRNA-like molecules in appar-
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by dsRNA may be involved in induction of interferon-b and Shenk, 1991), and the tar region of the HIV-1 RNA
(Maitra et al., 1994; Silverman and Sengupta, 1990; Gun-gene expression and of the other cellular genes whose
nery et al., 1990, 1992; Edery et al., 1989; Sengupta andtranscription is influenced by dsRNA. PKR-mediated
Silverman, 1989; Schroder et al., 1990). PKR binds to RNAphosphorylation of histone proteins has only been de-
with Kds in the nM range (McCormack and Samuel, 1995;tected in vitro and its biological significance is at present
Schmedt et al., 1995). For PKR, the amino-terminal thirdunclear. Activated PKR may also be able to induce
of the protein appears to be both necessary and sufficientapoptosis in vaccinia virus-infected cells (Lee and Es-
for binding to dsRNA (McCormack et al., 1992; Patel andteban, 1994), although neither the activators nor sub-
Sen, 1992; Feng et al., 1992; Katze et al., 1991). Thisstrates involved in this response have been character-
region contains two copies of a motif that has been foundized. Inhibition of endogenous PKR, either by expression
in a number of proteins that bind specifically to dsRNAof dominant negative mutants of PKR (Koromilas et al.,
or structured RNA (St. Johnston et al., 1993; Chang et al.,1992; Meurs et al., 1993) or by expression of a natural
1992; Chang and Jacobs, 1993; McCormack et al., 1992).cellular inhibitor of PKR (Barber et al., 1994) produced a
Both copies of the motif appear necessary for high affinitytransformed phenotype in cells, as did overexpression
binding of PKR to dsRNA, although the amino-proximalof a nonphosphorylatable mutant of eIF-2a (Donze et al.,
motif seems to be more important for binding and activity1995). PKR has been found in most mammalian cells
than the internal motif. Mutation of several residues inanalyzed. An analogous enzyme, which is immunologi-
PKR, conserved among most proteins containing the mo-cally cross-reactive with human PKR, has been identified
tif, interfered with binding to dsRNA (McCormack et al.,in plant cells (Langland et al., 1995) and is inducible by
1994; Green et al., 1995; Romano et al., 1995; McMillanvirus and viroid infection (Crum et al., 1988; Hiddinga et
et al., 1995; Clarke and Mathews, 1995).al., 1988; Roth and He, 1994).
The dsRNA-binding domain for the 2*,5* oligoadenylateActivation of 2*,5* oligoadenylate synthetase by dsRNA
synthetases has not been as well defined as the domainsis likely not a consequence of a posttranslational modifi-
on PKR. Sequences within the amino-terminal 158 resi-cation, but of a conformational change in the enzyme
dues on the small (42-kDa) isoform of 2*,5* oligoadenyl-induced by binding to dsRNA. Once activated, the en-
ate synthetase are necessary for binding to dsRNAzyme can polymerize ATP and other nucleotides in novel
(Ghosh et al., 1991). This region of 2*,5* oligoadenylate2*,5* linkages (Kerr and Brown, 1978). These 2*,5* oli-
synthetase contains no sequences homologous to anygoadenylates can activate a ribonuclease, RNase L, that
other proteins in the database. The cDNA clone of thecan cleave ssRNAs, including rRNA, at UpA, UpG, or
larger, 69-kDa isoform of 2*,5* oligoadenylate synthetaseUpU residues (Silverman et al., 1988; Bisbal et al., 1989;
contains a duplication of sequences homologous to theBaglioni et al., 1979; Nilsen et al., 1982; Schroder et al.,
small isoform of 2*,5* oligoadenylate synthetase (Marie1989; Floyd-Smith et al., 1981; Wreschner et al., 1981).
and Hovanessian, 1992). As of yet the sequences neces-Several isoforms of 2*,5* oligoadenylate synthetase have
sary for the 69-kDa isoform to bind to dsRNA have notbeen identified, and cDNA clones for two of the isoforms
been identified.have been characterized (Laurent et al., 1983; Yang et
Both PKR and the various forms of 2*,5* oligoadenylateal., 1981; Chebath et al., 1987a; Saunders et al., 1985;
synthetase have been found in the cytoplasm as well asIlson et al., 1986; Rosenblum et al., 1988; Marie et al.,
the nucleus (Jimenez Garcia et al., 1993; Jeffrey et al.,1990; Wathelet et al., 1986). The smaller of the two iso-
1995; Saunders et al., 1985; Rosenblum et al., 1988) offorms of 2*,5* oligoadenylate synthetase appears to be
cells. For PKR approximately 80% of the enzyme is foundsufficient to inhibit replication of EMCV and vaccinia virus
in the cytoplasm while 20% is found in the nucleus (Jeffreybut not VSV in cells transfected with plasmid engineered
et al., 1995). The nuclear form of the enzyme was concen-to constitutively express the enzyme (Chebath et al.,
trated in nucleoli and was apparently relatively under-1987b; Grun et al., 1987). In addition, expression of anti-
phosphorylated, compared to cytoplasmic enzyme. Thesense RNA to the small isoform of 2*,5* oligoadenylate
cytoplasmic form of PKR is both associated with ribo-synthetase prevented the interferon-mediated inhibition
somes (80%) and free in the cytoplasm (20%). Cyto-of EMCV replication (Benedetti et al., 1987), as did ex-
plasmic PKR not bound to ribosomes is partially phos-pression of a dominant negative mutant of RNase L (Has-
phorylated and a dimer (Langland and Jacobs, 1992).sel et al., 1993). Both negative and positive sense picor-
The different roles that these differentially localized and
naviral RNA have been found bound to 2*,5* oligoadeny-
differentially phosphorylated forms of the kinase play in
late synthetase in EMCV-infected cells (Gribaudo et al.,
inhibition of virus replication or in normal cell physiology
1991), consistent with activation of the pathway in picor- is at present unclear.
navirus-infected cells.
VIRAL MODULATORS OF THE RESPONSEBoth PKR and 2*,5* oligoadenylate synthetase bind
TO dsRNAspecifically to dsRNA or RNA with secondary structure,
including the reovirus s1 mRNA (Bischoff and Samuel, Given the efficiency of the dsRNA-dependent enzymes
at inhibiting virus infection, it is perhaps not surprising1989), adenovirus VAI RNA (Desai et al., 1995; Mathews
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that a number of viruses have evolved pathways to coun- deleted for K3L is interferon sensitive (Beattie et al.,
1991), but does not have a host range different fromteract activation and/or activity of both 2*,5* oligoadeny-
late synthetase and PKR. The most well-characterized wild-type vaccinia virus (see below) and does not induce
apoptosis in infected cells (Lee and Esteban, 1994).PKR inhibitor is the adenovirus VAI RNA (Mathews and
Shenk, 1991). VAI RNA is found in abundant amounts The vaccinia virus E3L gene codes for a second modu-
lator of dsRNA in virus-infected cells. The E3L geneat late times after infection with adenovirus. A second
adenovirus-encoded small RNA, VAII RNA, is synthesized codes for two proteins that can both bind specifically to
dsRNA (Watson and Jacobs, 1991; Chang et al., 1992;in lower amounts in infected cells. Virus deleted for VAI
replicates poorly, while virus deleted for VAII replicates Yuwen et al., 1993). Cloned E3L gene products can inhibit
activation of PKR (Chang et al., 1992). Inhibition in vitroas well as wild-type virus (Thimmappaya et al., 1982).
VAI RNA is highly structured in solution (Furtado et al., appears not to be catalytic (Whitaker-Dowling and Youn-
gner, 1983; Jagus and Gray, 1994) and can be overcome1989; Mellits and Mathews, 1988) and binds to PKR in
competition with dsRNA (Galabru et al., 1989; Katze et with increasing concentrations of dsRNA (Whitaker-Dow-
ling and Youngner, 1983; Watson and Jacobs, 1991). De-al., 1987; Kostura and Mathews, 1989; Mellits et al., 1990)
but fails to efficiently lead to PKR autophosphorylation or letion of the E3L gene from vaccinia virus leads to loss
of kinase inhibitory activity and to degradation of rRNAactivation. The ability to bind to PKR in competition with
dsRNA is not sufficient for VAI function, since several characteristic of activation of the 2*,5* oligoadenylate
synthetase/RNase L pathway (Beattie et al., 1995a). Virusmutants of VAI that bind PKR in vitro do not effectively
support adenovirus replication (Mellits et al., 1990). Bind- deleted for E3L has a host-range phenotype, in that it
will replicate in RK-13 and CEF cells but not in HeLa oring to PKR requires an apical stem structure of at least
half a turn in length (Clarke et al., 1994), but a central Vero cells (Beattie et al., 1995a,b; Chang et al., 1995).
Replication in L cells is semipermissive (Beattie et al.,domain of complex structure is required to inhibit PKR
activation (Pe’ery et al., 1993; Ghadge et al., 1994). Dele- 1995). In those cells in which virus deleted for E3L does
replicate, replication is sensitive to the anti-viral effectstion of the VAI gene leads to a virus that replicates poorly
and is sensitive to the antiviral effects of interferon (Thim- of interferon (wild-type vaccinia virus is resistant to the
effects of interferon in most cell types tested) (Beattie etmappaya et al., 1982; Kitajewski et al., 1986). Analogous
Epstein–Barr virus-encoded structured small RNAs (EB- al., 1995a; Chang et al., 1995). Virus deleted for E3L in-
duces apoptosis in HeLa cells (Lee and Esteban, 1994).ERs) can inhibit activation of PKR (Clarke et al., 1991;
Sharp et al., 1993; Clemens et al., 1994). The Epstein– Thus, the host-range phenotype may be a consequence
of induction of apoptosis in cells. Induction of apoptosisBarr virus encoded small RNAs can at least partially
complement adenovirus deleted for VAI RNA (Bhat and by virus deleted for E3L, together with the fact that PKR
expressed from wild-type vaccinia virus inducesThimmappaya, 1983) as can SV-40 large T antigen (Rajan
et al., 1995). However, the role of at least the Epstein– apoptosis (Lee and Esteban, 1994), suggests that viral
dsRNA may be inducing apoptosis by activating PKR.Barr virus encoded small RNAs in infected cells is un-
clear since deletion of the gene for these RNAs has no Results on influenza virus-mediated induction of
apoptosis suggest that dsRNA might mediate its effectseffect on sensitivity of the virus to interferon treatment
(Swaminathan et al., 1992). EBERs have been shown to by induction of fas antigen, again, perhaps through acti-
vation of PKR (Takizawa et al., 1995). Several other pro-bind to the ribosomal protein L22 (Toczyski et al., 1994).
Again, the functional significance of binding to L22 is at teins that can bind to dsRNA can substitute for E3L in
allowing replication in HeLa cells (Park et al., 1994; Lang-present unclear. VAI RNA can interact with 2*,5* oli-
goadenylate synthetase, but activates rather than inhibits land et al., 1994; Beattie et al., 1995a). Interestingly, the
E3L gene products are detected primarily in the nucleusthe enzyme (Desai et al., 1995). As is true of many of the
macromolecules described in this review, VAI RNA could at early times after infection and in transfected cells (Yu-
wen et al., 1993). The role that migration of these genebe detected in the nucleus as well as the cytoplasm of
infected and transfected cells (Jimenez Garcia et al., products to the nucleus plays in virus replication is at
present unclear, although a mutant of E3L encoding a1993). The role that nuclear localization of VAI RNA plays
in virus replication is at present unclear. protein that fails to migrate to the nucleus could rescue
the host-range defect of vaccinia virus deleted for E3LVaccinia virus-infected cells contain at least two prod-
ucts capable of inhibiting PKR. The protein product of the (Chang et al., 1995).
The vaccinia virus E3L gene contains a single copy ofK3L gene has partial homology to one of the substrates of
PKR, eIF-2a (Beattie et al., 1991; Goebel et al., 1990), the dsRNA-binding motif also found in PKR (Chang et al.,
1992). Deletion and point mutation analysis indicates thatand can inhibit phosphorylation of this protein synthesis
initiation factor (Carroll et al., 1993; Davies et al., 1992, this motif is necessary for binding of the E3L gene prod-
ucts to dsRNA (Chang and Jacobs, 1993). The ability of1993; Jagus and Gray, 1994). The K3L gene product is
thought to function by binding to PKR competitively with mutants of E3L to support replication of vaccinia virus in
HeLa cells correlates with their ability to bind dsRNAeIF-2 (Carroll et al., 1993; Jagus and Gray, 1994). Virus
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(Chang et al., 1995). A similar motif is found in the porcine stimulate translation of reporter mRNAs containing 5*
untranslated regions of influenza virus mRNAs (Enami etgroup C rotavirus NSP3 gene (Langland et al., 1994).
While a direct mutational analysis of NSP3 gene function al., 1994). The hantavirus core protein appears also to
bind to ssRNA and dsRNA (Gott et al., 1993), while theis not possible due to the lack of a gene replacement
system in rotaviruses, the NSP3 gene can fully comple- reovirus l1 protein can bind to either dsRNA or dsDNA
(Lemay and Danis, 1994).ment deletion of the E3L gene in vaccinia virus. The
NSP3 gene is predicted to encode a 45-kDa protein. HIV-infected cells contain a number of macromole-
cules capable of modulating the activity of PKR. As indi-However, when NSP3 is expressed either in vitro, or in
transfected cells, the 45-kDa product is cleaved into 38- cated previously, the tar stem–loop structure at the 5*-
end of HIV genome RNA and mRNA can bind to PKRand 8-kDa proteins. The 8-kDa protein contains the
dsRNA-binding motif and binds to dsRNA. This 8-kDa (Maitra et al., 1994; Silverman and Sengupta, 1990; Gun-
nery et al., 1990, 1992; Edery et al., 1989). PKR binds topolypeptide has been detected in cells infected with
group C rotaviruses (Langland et al., 1994), and thus is tar with 100-fold lower affinity than to either fully duplexed
RNA or VAI RNA (McCormack and Samuel, 1995). Alter-the smallest known natural protein that can specifically
bind dsRNA and antagonize at least some of the effects native investigators have argued that tar RNA sequences
can either activate (Maitra et al., 1994; Edery et al., 1989)of dsRNA.
The reovirus s3 protein can also bind specifically to or antagonize (Gunnery et al., 1992) activation of PKR.
Interaction of PKR with tar could be inhibited by tat pro-dsRNA (Huismans and Joklik, 1976), even though it has,
at best, limited homology to other known dsRNA-binding tein (Judware et al., 1993).
proteins. s3 can inhibit PKR activation in vitro (Imani
and Jacobs, 1988) and in transfected cells (Giantini and CELLULAR MODULATORS OF THE RESPONSE
Shatkin, 1989; Lloyd and Shatkin, 1992; Denzler and Ja- TO dsRNA
cobs, 1994). The gene encoding s3 (S4) can also partially
complement deletion of E3L from vaccinia virus (Beattie Uninfected cells also contain a number of factors
capable of modifying the effects of dsRNA. Human, bo-et al., 1995a) and deletion of VAI from adenovirus (Lloyd
and Shatkin, 1992). Some strains of reovirus are relatively vine, mouse, and monkey cells contain a latent inhibitor
of PKR, termed P58 (Lee et al., 1990, 1992, 1994b; Leeresistant to the effects of interferon while other strains
are quite sensitive (Jacobs and Ferguson, 1991). As of and Katze, 1994; Barber et al., 1994). The latent inhibitor
could be separated from an ‘‘anti-inhibitor’’ either byyet the gene encoding resistance of reovirus to interferon
has not been identified. Strains of reovirus also differ in precipitation with ammonium sulfate or by infection
with influenza virus (Lee et al., 1990). Active inhibitortheir ability to inhibit translation of host mRNAs. The abil-
ity of reovirus to inhibit host protein synthesis maps to decreases both PKR activation and activity toward eIF-
2a, in an unknown manner (Lee et al., 1990). The genethe gene encoding s3 (Sharpe and Fields, 1982). While
all strains of mammalian reovirus thus far analyzed code for P58 has been cloned, sequenced, and expressed.
The protein is a member of a family of proteins, calledfor a s3 protein capable of binding dsRNA (Seliger et al.,
1992), there may be strain differences in the affinity of the tetratricopeptide family, which includes cdc23,
cdc16, and bimA, that may be involved in regulation ofs3 for dsRNA, in the amount of s3 made in infected cells,
or in the ability of s3 to bind to another viral protein, m1, the cell cycle (Barber et al., 1994; Lee et al., 1994b).
Overexpression of P58 results in transformation of cellswhich can abrogate binding of s3 to dsRNA. Binding to
dsRNA has been mapped to a basic region in the car- in culture, presumably by inhibiting endogenous PKR
(Barber et al., 1994; Lee et al., 1994b).boxy-half of the protein (Schiff et al., 1988; Miller and
Samuel, 1992; Denzler and Jacobs, 1994; Mabrouk et al., Uninfected cells also contain an eIF-2 associated pro-
tein, called p67 (Datta et al., 1989) that can block PKR-1995). Mutations of the protein in this domain that inhibit
dsRNA-binding fail to support replication of vaccinia virus mediated phosphorylation of either eIF-2a or histone pro-
teins (Ray et al., 1992). p67 has also been reported todeleted for E3L in HeLa cells (Beattie et al., 1995a).
In addition to the specific dsRNA-binding noted for the block autophosphorylation of PKR (Ray et al., 1992). p67
may be a general inhibitor of eIF-2a phosphorylation inE3L gene products and s3, several viral proteins appear
to bind to several different nucleic acids, including that it can prevent phosphorylation mediated by the heme
regulated eIF-2a kinase (Ray et al., 1993). The inhibitordsRNA. The influenza virus NS-1 protein can bind to both
negative sense influenza virus RNA (Hatada et al., 1992) is degraded in serum-starved cells and its synthesis is
induced by subsequent mitogen treatment (Ray et al.,and dsRNA (Hatada and Fukuda, 1992). NS-1 protein can
act as an inhibitor in vitro of PKR and can block the 1992). Activity of the inhibitor may also be regulated by
deglycosylation (Datta et al., 1989).dsRNA-mediated inhibition of translation in vitro (Qian et
al., 1995; Lu et al., 1995). In addition, mutants of NS-1 Undifferentiated preadipocytes contain a 15-kDa pro-
tein inhibitor of PKR (Judware and Petryshyn, 1991,have been shown to alter translation of viral RNAs in
infected cells, and NS-1 expressed in HeLa cells can 1992). The inhibitor appears to block interaction of PKR
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with dsRNA, but does not interact with dsRNA activator being substrates for PKR, bind to dsRNA as well as to
dsDNA and can prevent activation of PKR in vitro (Jacobs(Judware and Petryshyn, 1992). It has been suggested
that the inhibitor binds directly to PKR to block its inter- and Imani, 1988). Given the recent identification of PKR
in the nucleus of cells these proteins may be acting asaction with dsRNA.
The human cellular protein, TRBP (Gatignol et al., inhibitors and/or substrates of PKR in cells.
1991), has been shown to bind to dsRNA (Gatignol et al.,
1993; Park et al., 1994) and to inhibit activation of PKR CONCLUDING REMARKS
in vitro (Park et al., 1994). TRBP contains three copies of
the dsRNA-binding motif (Gatignol et al., 1993; Park et The role of dsRNA in the response of cells to virus
infection has been evident for a number of years. Oural., 1994). Overexpression of TRBP can complement the
host-range defect of vaccinia virus deleted for the E3L increased understanding of the resources that viruses
invest to protect themselves from this response addsgene (Park et al., 1994). The role of TRBP in uninfected
and in virus-infected cells is at present unclear, although credence to the critical role of dsRNA in the cells recogni-
tion and response to virus infection. The potential rolehuman TRBP can bind to tar and RRE sequences on HIV
RNA (Gatignol et al., 1991, 1993; Park et al., 1994) and of dsRNA in uninfected cells is just beginning to be
gleaned. The future will no doubt see great progresscan coimmunoprecipitate HIV RNA from infected cells
(Gatignol et al., 1993). A similar protein has been identi- in our understanding of the interaction between cellular
RNAs and the dsRNA-activated machinery in cells, prog-fied in Xenopus levis cells (St. Johnston et al., 1993).
An adenosine deaminase that uses dsRNA as a sub- ress that will almost certainly utilize the reagents that
viruses have given to us as probes.strate (dsRNA adenosine deaminase, DRADA) has been
identified in a number of cells (O’Connell and Keller, 1994;
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